TDACU — Translational Development Acquisition Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsSpeculativeSmall CapNeutral

Annual balance sheet for Translational Development Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	—	USG	USG
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.002	0.438
Prepaid Expenses
Total Current Assets	0.054	0.002	0.65
Long Term Investments
Other Long Term Assets
Total Assets	0.437	0.002	175
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.459	0.51	0.21
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.459	0.51	6.25
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.022	-0.508	169
Total Liabilities & Shareholders' Equity	0.437	0.002	175
Total Common Shares Outstanding